Vanda Pharmaceuticals
VNDA
VNDA
188 hedge funds and large institutions have $371M invested in Vanda Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 76 increasing their positions, 61 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.62% less ownership
Funds ownership: 102.55% → 97.93% (-4.6%)
6% less capital invested
Capital invested by funds: $396M → $371M (-$25M)
Holders
188
Holding in Top 10
1
Calls
$638K
Puts
$30K
Top Buyers
| 1 | +$4.69M | |
| 2 | +$2.98M | |
| 3 | +$2.29M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.91M |
| 5 |
Man Group
London,
United Kingdom
|
+$1.8M |
Top Sellers
| 1 | -$8.52M | |
| 2 | -$7.79M | |
| 3 | -$5.5M | |
| 4 |
EIP
Epoch Investment Partners
New York
|
-$4.8M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$3.93M |